Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Roxiwel-150 (Roxithromycin 150 mg) Tablet is a macrolide antibiotic used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and multiplication. This medication is particularly effective against infections caused by susceptible strains of bacteria.
Key Uses:
Treatment of respiratory tract infections such as bronchitis and pneumonia.
Management of skin and soft tissue infections.
Treatment of urogenital infections, including urethritis and cervicitis.
Benefits:
Broad-spectrum antibacterial action.
Well-tolerated with a lower risk of gastrointestinal disturbances compared to other macrolides.
Convenient dosing regimen for improved patient compliance.
Mechanism of Action:
Roxithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing peptide chain elongation and bacterial replication. This bacteriostatic effect helps in controlling and eliminating infections efficiently.